β-Synuclein: An Enigmatic Protein with Diverse Functionality

Area of Science:

• Neuroscience
• Molecular Biology
• Protein Biochemistry

Background:

• Alpha-synuclein (αS) aggregation is central to Parkinson's disease pathology.
• Beta-synuclein (βS) is co-expressed with αS and can inhibit αS aggregation in vitro.
• Emerging evidence suggests βS has roles beyond αS interaction, potentially contributing to neurotoxicity.

Purpose of the Study:

• To comprehensively review the literature on human βS.
• To elucidate the independent roles of βS in cellular homeostasis and neurological disease.
• To understand βS's structure, function, and involvement in pathology.

Main Methods:

• Literature review of scientific articles on human βS.
• Analysis of βS structure and its chaperone activity.
• Exploration of βS's involvement in synaptic function, apoptosis, protein degradation, metal modulation, and toxicity.

Main Results:

• βS exhibits diverse functions including molecular chaperoning, synaptic regulation, and mediation of apoptosis.
• βS can modulate intracellular metal levels and participate in protein degradation pathways.
• Specific βS mutations (P123H, V70M) are linked to dementia with Lewy bodies.

Conclusions:

• βS has complex interactions with αS, acting both synergistically and antagonistically.
• βS possesses significant cellular functions independent of αS.
• Further research into βS is crucial for understanding its role in neurological health and disease.